Biological markers and psychophysiological methods as long term response predictors to fluoxetine treatment.
Fountoulakis
Konstantinos N
KN
Kaprinis
Stergios
S
Iacovides
Apostolos
A
Fotiou
Fotis
F
Kaprinis
George
G
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000328:Adult; D002908:Chronic Disease; D003863:Depression / Q000188:drug therapy*; D003907:Dexamethasone / Q000494:pharmacology; D020372:Dexfenfluramine / Q000494:pharmacology; D004334:Drug Administration Schedule; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D011388:Prolactin / Q000378:metabolism; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D003907:Dexamethasone; D020372:Dexfenfluramine; D005473:Fluoxetine; D011388:Prolactin; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors